Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds US Conference Bd Oct Consumer Confidence 102.5 Vs Sep 107.8

Econ #s
News

US Conference Bd Oct Consumer Confidence 102.5 Vs Sep 107.8

-Dow Jones

byBenzinga Newsdesk

October 25, 2022

1 minute read

-Dow Jones

89bio Announces U.S. FDA Has Granted Breakthrough Therapy Designation For Pegozafermin In Nonalcoholic Steatohepatitis

By Benzinga Newsdesk

September 21, 8:09 AM

–Supported by positive data in F2/F3 and F4 NASH patients from the ENLIVEN Phase 2b trial of pegozafermin– –Discussions with regulatory agencies regarding the NASH Phase 3 program planned for the fourth quarter of

ETNB

Wolfe Research Initiates Coverage On Ansys with Outperform Rating, Announces Price Target of $320

By Benzinga Newsdesk

August 17, 9:51 AM

Wolfe Research analyst Gal Munda initiates coverage on Ansys (NASDAQ:ANSS) with a Outperform rating and announces Price Target of $320.

ANSS

Is Apple Losing Its Spark? Recent Sales Figures Suggest So.

By Bibhu Pattnaik

September 17, 12:43 PM

While the market is upbeat about the new iPhone 15 from Apple Inc. (NASDAQ:

AAPL

Nvidia, BJ’s Wholesale Club And 3 Stocks To Watch Heading Into Thursday

By Avi Kapoor

May 23, 2:02 AM

With U.S. stock futures trading higher this morning on Thursday, some of the stocks that may grab investor…

US Conference Bd Oct Consumer Confidence 102.5 Vs Sep 107.8

Related Posts

89bio Announces U.S. FDA Has Granted Breakthrough Therapy Designation For Pegozafermin In Nonalcoholic Steatohepatitis

Wolfe Research Initiates Coverage On Ansys with Outperform Rating, Announces Price Target of $320

Is Apple Losing Its Spark? Recent Sales Figures Suggest So.

Nvidia, BJ’s Wholesale Club And 3 Stocks To Watch Heading Into Thursday